Jan Petracek at the Prestigious Intelligent Automation in Pharmacovigilance Seminar in Boston
Dec 12, 2017
Jan Petracek, CEO of PharmInvent, presented last week “The Optimal Service Mix for 2020” at the prestigious intelligent automation in pharmacovigilance seminar organised by PrimeVigilance, sister company of PharmInvent together with the International Society of Pharmacovigilance held at Biogen‘s headquarters in Cambridge, MA, from 4-5 December 2017.
This seminar was the first of its kind worldwide to cover this complex development area, with over 30 speakers from the most influential companies in pharmacovigilance automation who presented their state of the art technologies and examined the disruption expected within the industry. Some of the participating bodies included: AstraZeneca, Bayer, Biogen, Celgene, Genentech, Takeda and the FDA and the MHRA. Jan Petracek presented the results from its successful pilot project demonstrating how robotic process automation of selected pharmacovigilance systems can increase efficiency by up to 400 times, increasing speed, reducing cost and improving accuracy. PrimeVigilance is looking forward to the next leap forward in technology for our industry and the next seminar about this hot topic. For more information and any questions please contact firstname.lastname@example.org.